[11C]PiB | n | Age (months) | Weight (g) | Inj. Activity (MBq) | Inj. Mass (nmol/kg) | Molar activity (GBq/μmol) |
---|---|---|---|---|---|---|
Female APP/hTau | 3 | 6.7 ± 0.3 | 257.7 ± 32.7 | 23.6 ± 6.1 | 3.2 ± 1.2 | 29.9 ± 5.0 |
Male APP/hTau | 3 | 7.1 ± 0.1 | 493.0 ± 51.4 | 26.3 ± 0.7 | 6.1 ± 4.1 | 16.2 ± 16.8 |
Female APP/hTau | 8 | 12.1 ± 0.6 | 334.5 ± 30.8 | 14.8 ± 2.2 | 0.4 ± 0.1 | 115.1 ± 12.9 |
Male APP/hTau | 10 | 12.4 ± 0.7 | 540.6 ± 47.6 | 16.7 ± 3.3 | 0.3 ± 0.0 | 109.3 ± 22.7 |
Female APP/hTau | 8 | 20.5 ± 0.5 | 347.0 ± 48.8 | 21.1 ± 1.1 | 0.6 ± 0.2 | 21.1 ± 1.1 |
Male APP/hTau | 10 | 20.6 ± 0.3 | 606.9 ± 43.8 | 31.0 ± 16.8 | 0.5 ± 0.3 | 31.0 ± 16.8 |
[18F]THK-5317 | n | Age (months) | Weight (g) | Inj. Activity (MBq) | Inj. Mass (nmol/kg) | Molar activity (GBq/μmol) |
Female ntg | 6 | 7.0 ± 0.2 | 273.3 ± 17.6 | 19.2 ± 5.2 | 1.5 ± 0.6 | 52.5 ± 16.7 |
Female APP/hTau | 7 | 7.0 ± 0.4 | 263.4 ± 21.2 | 17.8 ± 3.1 | 1.4 ± 1.7 | 149.9 ± 122.8 |
Male ntg | 6 | 7.1 ± 0.1 | 491.2 ± 57.5 | 16.2 ± 3.8 | 0.7 ± 0.1 | 53.7 ± 15.2 |
Male APP/hTau | 7 | 7.1 ± 0.3 | 485.6 ± 65.8 | 17.4 ± 3.8 | 0.3 ± 0.1 | 182.0 ± 118.6 |
Female ntg | 6 | 12.8 ± 0.5 | 300.3 ± 38.0 | 15.0 ± 1.5 | 0.9 ± 0.5 | 71.3 ± 45.1 |
female APP/hTau | 11 | 12.5 ± 0.5 | 319.7 ± 28.7 | 11.6 ± 4.3 | 0.7 ± 0.6 | 83.6 ± 66.3 |
Male ntg | 2 | 13.4 ± 0.4 | 632.5 ± 0.7 | 8.8 ± 3.9 | 0.4 ± 0.5 | 194.8 ± 257.6 |
male APP/hTau | 10 | 12.9 ± 0.4 | 520.3 ± 53.4 | 15.9 ± 4.3 | 0.4 ± 0.3 | 135.4 ± 99.1 |
Female ntg | 4 | 20.7 ± 0.4 | 354.0 ± 82.9 | 18.5 ± 2.6 | 0.9 ± 1.0 | 103.1 ± 46.1 |
Female APP/hTau | 6 | 20.7 ± 0.6 | 342.8 ± 52.1 | 16.2 ± 1.2 | 0.2 ± 0.1 | 388.9 ± 236.8 |
Male ntg | 4 | 21.0 ± 0.3 | 538.3 ± 54.4 | 16.3 ± 2.5 | 0.6 ± 0.5 | 88.0 ± 70.8 |
Male APP/hTau | 10 | 20.9 ± 0.3 | 594.5 ± 48.9 | 15.2 ± 2.6 | 0.2 ± 0.3 | 181.4 ± 112.6 |